Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04372485 · ClinicalTrials.gov registry record · NA

Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents

A NA study of Sexually Transmitted Diseases, sponsored by Children's National Research Institute.

Recruiting
Registry status
NA
Development phase
270
Enrollment target
1
Study location

NCT04372485 is a NA study of Sexually Transmitted Diseases that is actively recruiting participants, run by Children's National Research Institute. The registered enrollment target is 270 participants, below the 1,243-participant average among 35 other Sexually Transmitted Diseases trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04372485, a NA study of Sexually Transmitted Diseases, is actively recruiting participants, sponsored by Children's National Research Institute.

RECRUITING
Registry status
NA
Development phase
270 participants
Enrollment target
1
Study location

Study Summary

We will conduct a randomized trial to compare differences in sexually transmitted infection (STI) treatment adherence between patients receiving text messages versus those receiving usual care (e.g. no text messages). We hypothesize that STI treatment adherence will be 20% higher among patients randomized to receipt of two-way text messaging services.

Interventions

  • BEHAVIORAL mHealth Intervention

Study Locations (1)

District of Columbia

  • Children's National Hospital - Washington D.C.

Trial Details

FieldValue
Enrollment Target 270 participants
Start Date 2024-06-03
Est. Completion 2027-06
Phase NA

What the Registry Record Tells You About NCT04372485

The ClinicalTrials.gov registry entry for NCT04372485 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,243-participant average among 35 other Sexually Transmitted Diseases trials with a reported enrollment target (78% lower). The listed sponsor is Children's National Research Institute, which has 92 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sexually Transmitted Diseases appearing as the primary indexed condition, and to 1 intervention - of which mHealth Intervention is the first listed.

NCT04372485 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT04372485 about?

NCT04372485 is a clinical study titled "Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents". We will conduct a randomized trial to compare differences in sexually transmitted infection (STI) treatment adherence between patients receiving text messages versus those receiving usual care (e.g. no text messages). We hypothesize that STI treatment adherence will be 20% higher among patients rand...

What is the current status of trial NCT04372485?

This trial is currently recruiting. It is a NA study. The enrollment target is 270 participants. The study started on 2024-06-03. Estimated completion is 2027-06.

What conditions does trial NCT04372485 study?

This clinical trial studies the following conditions: Sexually Transmitted Diseases.

What interventions are being tested in trial NCT04372485?

The interventions under investigation include: mHealth Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04372485?

This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04372485 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sexually Transmitted Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.